ATE328080T1 - Proteine und für diese kodierende dna - Google Patents

Proteine und für diese kodierende dna

Info

Publication number
ATE328080T1
ATE328080T1 AT00974980T AT00974980T ATE328080T1 AT E328080 T1 ATE328080 T1 AT E328080T1 AT 00974980 T AT00974980 T AT 00974980T AT 00974980 T AT00974980 T AT 00974980T AT E328080 T1 ATE328080 T1 AT E328080T1
Authority
AT
Austria
Prior art keywords
protein
present
activity
inhibiting
diseases
Prior art date
Application number
AT00974980T
Other languages
English (en)
Inventor
Atsushi Nakanishi
Shigeru Morita
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE328080T1 publication Critical patent/ATE328080T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00974980T 1999-11-15 2000-11-14 Proteine und für diese kodierende dna ATE328080T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32446799 1999-11-15

Publications (1)

Publication Number Publication Date
ATE328080T1 true ATE328080T1 (de) 2006-06-15

Family

ID=18166147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974980T ATE328080T1 (de) 1999-11-15 2000-11-14 Proteine und für diese kodierende dna

Country Status (9)

Country Link
US (2) US6844179B1 (de)
EP (1) EP1231270B1 (de)
KR (1) KR20020059726A (de)
CN (1) CN1390256A (de)
AT (1) ATE328080T1 (de)
AU (1) AU1309601A (de)
CA (1) CA2391403A1 (de)
DE (1) DE60028407T2 (de)
WO (1) WO2001036633A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040053100A (ko) * 2001-07-24 2004-06-23 예일 유니버시티 키티나아제, 키티나아제 유사 분자 및 염증성 질환과관련된 방법, 조성물 및 키트
CA2457565A1 (en) 2001-10-09 2003-04-17 Genentech, Inc. Novel acidic mammalian proteins and polynucleotides encoding the same
US20030087414A1 (en) * 2001-11-02 2003-05-08 Aerts Johannes Maria Franciscus Gerardus Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
US7632654B2 (en) * 2002-04-29 2009-12-15 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Means and methods for detecting endoglycosidase activity
EP1729805A4 (de) * 2004-02-25 2008-11-26 Medimmune Inc Verfahren und zusammensetzungen im zusammenhang mit chitinasen und chitinase-artigen molekülen und modulierung von osteoklasten
JP4856381B2 (ja) * 2005-03-03 2012-01-18 大鵬薬品工業株式会社 ヒトオロト酸ホスホリボシルトランスフェラーゼタンパク質の測定法
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
WO2008002548A2 (en) * 2006-06-28 2008-01-03 Merck & Co., Inc. Novel human acidic mammalian chitinase and use thereof
SG185062A1 (en) * 2010-04-26 2012-12-28 Univ Keio Self-renewal promoter for neural stem cells and method for using same

Also Published As

Publication number Publication date
DE60028407T2 (de) 2006-11-02
EP1231270A4 (de) 2003-08-13
DE60028407D1 (de) 2006-07-06
AU1309601A (en) 2001-05-30
EP1231270A1 (de) 2002-08-14
WO2001036633A1 (en) 2001-05-25
CN1390256A (zh) 2003-01-08
US20050163767A1 (en) 2005-07-28
KR20020059726A (ko) 2002-07-13
EP1231270B1 (de) 2006-05-31
US6844179B1 (en) 2005-01-18
CA2391403A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
ATE466883T1 (de) Katalytische monoklonale antikörper mit proteaseaktivität zur selektiven lysis der proteinkomponente von mit pathologischen konditionen zusammenhängenden plaques und aggregaten
HUP0302128A2 (hu) Anti-duális-integrin ellenanyagok, készítmények, eljárások és alkalmazások
ATE315938T1 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
AT500379A3 (de) Tau-proteine
ATE328080T1 (de) Proteine und für diese kodierende dna
WO2001064877A3 (en) Human schizophrenia gene
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
DE10292329D2 (de) Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
ATE480637T1 (de) Methode zur bestimmung der biologischen aktivität von difibrotid
DE602004025509D1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
EA200300152A1 (ru) Фармацевтический препарат сальметерола и пропионата флутиказона
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
PT816504E (pt) Acetil-hidrolase para o factor activador das plaquetas, e seu gene
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
DE10294286D2 (de) Herstellung von trägergebundenen Molekülen
WO2001064876A3 (en) Human schizophrenia gene
ATE323505T1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60043106D1 (de) Polypeptide und deren dna
WO2003100075A3 (en) Bsnd nucleic acids and proteins
DE60124523D1 (de) Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
ATE282609T1 (de) Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl) (1,4)diazepan-1-yl)-2- (aryl)butyl)benzamide zur behandlung von allergischen krankheiten
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties